Cargando…
Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support
A 69‐year‐old man was hospitalized for heart failure 7 days after coronavirus disease 2019 (COVID‐19) mRNA vaccination. Electrocardiography showed ST‐segment elevation and echocardiography demonstrated severe left ventricular dysfunction. Venoarterial extracorporeal membrane oxygenation and Impella...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288782/ https://www.ncbi.nlm.nih.gov/pubmed/35616026 http://dx.doi.org/10.1002/ehf2.13962 |
_version_ | 1784748524586401792 |
---|---|
author | Kimura, Mitsukuni Hashimoto, Toru Noda, Eri Ishikawa, Yusuke Ishikita, Akihito Fujino, Takeo Matsushima, Shouji Ide, Tomomi Kinugawa, Shintaro Nagaoka, Kazuhiro Ushijima, Tomoki Shiose, Akira Tsutsui, Hiroyuki |
author_facet | Kimura, Mitsukuni Hashimoto, Toru Noda, Eri Ishikawa, Yusuke Ishikita, Akihito Fujino, Takeo Matsushima, Shouji Ide, Tomomi Kinugawa, Shintaro Nagaoka, Kazuhiro Ushijima, Tomoki Shiose, Akira Tsutsui, Hiroyuki |
author_sort | Kimura, Mitsukuni |
collection | PubMed |
description | A 69‐year‐old man was hospitalized for heart failure 7 days after coronavirus disease 2019 (COVID‐19) mRNA vaccination. Electrocardiography showed ST‐segment elevation and echocardiography demonstrated severe left ventricular dysfunction. Venoarterial extracorporeal membrane oxygenation and Impella 5.0 were instituted because of cardiogenic shock and ventricular fibrillation. Endomyocardial biopsy demonstrated necrotizing eosinophilic myocarditis (NEM). Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) PCR test was negative. He had no infection or history of new drug exposure. NEM was likely related to COVID‐19 vaccination. He was administered 10 mg/kg of prednisolone following methylprednisolone pulse treatment (1000 mg/day for 3 days). Left ventricular function recovered and he was weaned from mechanical circulatory support (MCS). Follow‐up endomyocardial biopsy showed no inflammatory cell infiltration. This is the first report of biopsy‐proven NEM after COVID‐19 vaccination survived with MCS and immunosuppression therapy. It is a rare condition but early, accurate diagnosis and early aggressive intervention can rescue patients. |
format | Online Article Text |
id | pubmed-9288782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92887822022-07-19 Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support Kimura, Mitsukuni Hashimoto, Toru Noda, Eri Ishikawa, Yusuke Ishikita, Akihito Fujino, Takeo Matsushima, Shouji Ide, Tomomi Kinugawa, Shintaro Nagaoka, Kazuhiro Ushijima, Tomoki Shiose, Akira Tsutsui, Hiroyuki ESC Heart Fail Case Reports A 69‐year‐old man was hospitalized for heart failure 7 days after coronavirus disease 2019 (COVID‐19) mRNA vaccination. Electrocardiography showed ST‐segment elevation and echocardiography demonstrated severe left ventricular dysfunction. Venoarterial extracorporeal membrane oxygenation and Impella 5.0 were instituted because of cardiogenic shock and ventricular fibrillation. Endomyocardial biopsy demonstrated necrotizing eosinophilic myocarditis (NEM). Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) PCR test was negative. He had no infection or history of new drug exposure. NEM was likely related to COVID‐19 vaccination. He was administered 10 mg/kg of prednisolone following methylprednisolone pulse treatment (1000 mg/day for 3 days). Left ventricular function recovered and he was weaned from mechanical circulatory support (MCS). Follow‐up endomyocardial biopsy showed no inflammatory cell infiltration. This is the first report of biopsy‐proven NEM after COVID‐19 vaccination survived with MCS and immunosuppression therapy. It is a rare condition but early, accurate diagnosis and early aggressive intervention can rescue patients. John Wiley and Sons Inc. 2022-05-26 /pmc/articles/PMC9288782/ /pubmed/35616026 http://dx.doi.org/10.1002/ehf2.13962 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Reports Kimura, Mitsukuni Hashimoto, Toru Noda, Eri Ishikawa, Yusuke Ishikita, Akihito Fujino, Takeo Matsushima, Shouji Ide, Tomomi Kinugawa, Shintaro Nagaoka, Kazuhiro Ushijima, Tomoki Shiose, Akira Tsutsui, Hiroyuki Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support |
title | Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support |
title_full | Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support |
title_fullStr | Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support |
title_full_unstemmed | Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support |
title_short | Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support |
title_sort | fulminant necrotizing eosinophilic myocarditis after covid‐19 vaccination survived with mechanical circulatory support |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288782/ https://www.ncbi.nlm.nih.gov/pubmed/35616026 http://dx.doi.org/10.1002/ehf2.13962 |
work_keys_str_mv | AT kimuramitsukuni fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT hashimototoru fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT nodaeri fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT ishikawayusuke fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT ishikitaakihito fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT fujinotakeo fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT matsushimashouji fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT idetomomi fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT kinugawashintaro fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT nagaokakazuhiro fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT ushijimatomoki fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT shioseakira fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport AT tsutsuihiroyuki fulminantnecrotizingeosinophilicmyocarditisaftercovid19vaccinationsurvivedwithmechanicalcirculatorysupport |